Fabio Facchetti mainly investigates Immunology, Pathology, Antigen, Lymphoma and Immunohistochemistry. His Immunology study deals with Interleukin 12 intersecting with Natural killer cell and Interleukin 21. The concepts of his Pathology study are interwoven with issues in Internal medicine and Follicular dendritic cells.
His work carried out in the field of Antigen brings together such families of science as Progenitor cell, Molecular biology, Donor derived and Antibody, Monoclonal antibody. His biological study spans a wide range of topics, including Cancer research, Marginal zone, Disease and Gene expression profiling. His Immunohistochemistry research is multidisciplinary, incorporating perspectives in Protein kinase B, Sarcoma, Kidney transplantation, Immunofluorescence and Post transplant.
The scientist’s investigation covers issues in Pathology, Immunology, Internal medicine, Cancer research and Immunohistochemistry. Fabio Facchetti regularly links together related areas like Antigen in his Pathology studies. His Dendritic cell, Immune system, Antigen-presenting cell, T cell and Immunophenotyping study are his primary interests in Immunology.
Fabio Facchetti has included themes like Gastroenterology, Chronic hepatitis, Surgery and Oncology in his Internal medicine study. Cancer research connects with themes related to Mutation in his study. Immunohistochemistry is frequently linked to Antibody in his study.
Fabio Facchetti focuses on Cancer research, Pathology, Internal medicine, Lymphoma and Oncology. The Cancer research study combines topics in areas such as Mutation, Regulation of gene expression and Gene. His Pathology research includes elements of Cell of origin, Antigen and Follicular dendritic cells.
His work in Antigen tackles topics such as Intervillous space which are related to areas like Immune system. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Tenofovir. His studies in Lymphoma integrate themes in fields like breakpoint cluster region and B-cell receptor, B cell.
Fabio Facchetti mainly focuses on Cancer research, Pathology, Lymphoma, Follicular dendritic cells and Immunology. His work deals with themes such as Mutation, Regulation of gene expression, Gene, CD8 and Plasmacytoid dendritic cell, which intersect with Cancer research. Fabio Facchetti focuses mostly in the field of Plasmacytoid dendritic cell, narrowing it down to matters related to Bone marrow and, in some cases, Cutaneous melanoma, Melanoma, CD34 and Leukemia.
His Pathology research is multidisciplinary, relying on both Cell of origin, Immune system, Hematopathology and Antigen. His Follicular dendritic cells research focuses on Sarcoma and how it relates to Follicular dendritic cell sarcoma, Immunohistochemistry and Mesenchymal stem cell. His biological study focuses on Immunodeficiency.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.
Marina Cella;David Jarrossay;Fabio Facchetti;Olga Alebardi.
Nature Medicine (1999)
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Marina Cella;Anja Fuchs;William Vermi;Fabio Facchetti.
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Axel Bouchon;Fabio Facchetti;Markus A. Weigand;Marco Colonna.
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.
Marina Cella;Fabio Facchetti;Antonio Lanzavecchia;Marco Colonna.
Nature Immunology (2000)
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell–derived IL-2: a potential new link between adaptive and innate immunity
Todd A Fehniger;Megan A Cooper;Gerard J Nuovo;Marina Cella.
BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction
Andrzej Dzionek;Yoshiaki Sohma;Jun Nagafune;Marina Cella.
Journal of Experimental Medicine (2001)
European consensus on grading bone marrow fibrosis and assessment of cellularity.
Jürgen Thiele;Hans Michael Kvasnicka;Fabio Facchetti;Vito Franco.
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Rein Willemze;Lorenzo Cerroni;Werner Kempf;Emilio Berti.
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.
Andrés J. M. Ferreri;Elías Campo;John F. Seymour;Rein Willemze.
British Journal of Haematology (2004)
Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting
Maurilio Ponzoni;Andrés J.M. Ferreri;Elías Campo;Fabio Facchetti.
Journal of Clinical Oncology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: